Biotechnology
The Biotechnology industry has a total of 600 stocks, with a combined market cap of $1.13 trillion and total revenue of $105.29 billion.
Market Cap
1.13T
Revenue
105.29B
Profits
-41.72B
PE Ratio
n/a
Profit Margin
-39.62%
Dividend Yield
0.04%
600 Stocks
| No. | Symbol | Company Name | Market Cap | % Change | Volume | Revenue |
|---|---|---|---|---|---|---|
| 1 | VRTX | Vertex Pharmaceuticals Incorporated | 114.05B | -1.13% | 1,295,132 | 11.72B |
| 2 | REGN | Regeneron Pharmaceuticals, Inc. | 77.37B | -0.63% | 669,096 | 14.25B |
| 3 | ARGX | argenx SE | 49.27B | -1.38% | 415,704 | 3.68B |
| 4 | ALNY | Alnylam Pharmaceuticals, Inc. | 48.47B | -0.84% | 1,200,206 | 3.21B |
| 5 | ONC | BeOne Medicines AG | 38.37B | -1.23% | 287,581 | 4.97B |
| 6 | INSM | Insmed Incorporated | 34.86B | -0.16% | 2,623,198 | 447.02M |
| 7 | BNTX | BioNTech SE | 27.38B | 1.80% | 1,409,749 | 3.70B |
| 8 | RVMD | Revolution Medicines, Inc. | 23.43B | 1.06% | 3,691,974 | - |
| 9 | RPRX | Royalty Pharma plc | 23.21B | -0.37% | 5,151,396 | 2.35B |
| 10 | GMAB | Genmab A/S | 21.63B | 4.34% | 2,654,242 | 3.85B |
| 11 | INCY | Incyte Corporation | 20.80B | 2.44% | 2,128,109 | 4.81B |
| 12 | ROIV | Roivant Sciences Ltd. | 16.56B | 1.58% | 5,805,305 | 20.33M |
| 13 | MRNA | Moderna, Inc. | 15.86B | 2.47% | 19,490,064 | 2.23B |
| 14 | BBIO | BridgeBio Pharma, Inc. | 15.01B | -1.53% | 1,887,976 | 353.78M |
| 15 | SMMT | Summit Therapeutics Inc. | 13.61B | 5.00% | 2,849,660 | - |
| 16 | ASND | Ascendis Pharma A/S | 13.34B | 1.06% | 482,829 | 758.59M |
| 17 | IONS | Ionis Pharmaceuticals, Inc. | 12.77B | -0.77% | 2,121,497 | 966.96M |
| 18 | EXEL | Exelixis, Inc. | 12.18B | 2.61% | 1,722,259 | 2.29B |
| 19 | MDGL | Madrigal Pharmaceuticals, Inc. | 11.47B | 2.29% | 346,613 | 740.64M |
| 20 | RNA | Avidity Biosciences, Inc. | 10.93B | 0.15% | 1,012,455 | 20.87M |
| 21 | BMRN | BioMarin Pharmaceutical Inc. | 10.77B | 1.59% | 2,568,690 | 3.09B |
| 22 | TECH | Bio-Techne Corporation | 10.66B | 3.07% | 2,976,285 | 1.22B |
| 23 | JAZZ | Jazz Pharmaceuticals plc | 10.38B | 5.16% | 1,830,970 | 4.16B |
| 24 | ABVX | ABIVAX Société Anonyme | 9.80B | 4.49% | 1,464,458 | 6.23M |
| 25 | ARWR | Arrowhead Pharmaceuticals, Inc. | 9.06B | 0.56% | 1,852,622 | 829.45M |
| 26 | AXSM | Axsome Therapeutics, Inc. | 8.92B | 1.54% | 457,407 | 561.26M |
| 27 | HALO | Halozyme Therapeutics, Inc. | 8.58B | 1.80% | 1,342,730 | 1.24B |
| 28 | KRYS | Krystal Biotech, Inc. | 8.46B | -0.05% | 319,638 | 373.16M |
| 29 | NUVL | Nuvalent, Inc. | 8.37B | 6.59% | 574,563 | - |
| 30 | PRAX | Praxis Precision Medicines, Inc. | 8.18B | 6.28% | 655,722 | 7.46M |
| 31 | CYTK | Cytokinetics, Incorporated | 7.90B | 2.01% | 1,609,659 | 87.21M |
| 32 | RYTM | Rhythm Pharmaceuticals, Inc. | 7.56B | 5.14% | 494,448 | 174.33M |
| 33 | CAI | Caris Life Sciences, Inc. | 7.45B | 0.08% | 2,238,490 | 649.06M |
| 34 | PCVX | Vaxcyte, Inc. | 6.35B | 5.41% | 676,286 | - |
| 35 | PTCT | PTC Therapeutics, Inc. | 6.21B | 2.51% | 1,110,791 | 1.78B |
| 36 | KYMR | Kymera Therapeutics, Inc. | 6.02B | 1.46% | 405,430 | 43.74M |
| 37 | GPCR | Structure Therapeutics Inc. | 5.83B | 8.23% | 1,788,860 | - |
| 38 | BLTE | Belite Bio, Inc | 5.77B | -2.08% | 254,319 | - |
| 39 | COGT | Cogent Biosciences, Inc. | 5.75B | 7.11% | 1,932,802 | - |
| 40 | CRNX | Crinetics Pharmaceuticals, Inc. | 5.68B | 2.04% | 735,400 | 1.54M |
| 41 | APGE | Apogee Therapeutics, Inc. | 5.56B | 4.34% | 1,064,300 | - |
| 42 | IMVT | Immunovant, Inc. | 5.54B | 4.47% | 1,805,061 | - |
| 43 | CRSP | CRISPR Therapeutics AG | 5.42B | 1.26% | 1,769,510 | 38.34M |
| 44 | PTGX | Protagonist Therapeutics, Inc. | 5.33B | 4.76% | 1,052,623 | 209.22M |
| 45 | CELC | Celcuity Inc. | 5.30B | 9.86% | 504,091 | - |
| 46 | MIRM | Mirum Pharmaceuticals, Inc. | 4.69B | 0.23% | 492,692 | 471.79M |
| 47 | SRRK | Scholar Rock Holding Corporation | 4.65B | 4.11% | 1,442,995 | - |
| 48 | ACAD | ACADIA Pharmaceuticals Inc. | 4.54B | 1.51% | 951,830 | 1.05B |
| 49 | CGON | CG Oncology, Inc. | 4.48B | 5.57% | 1,099,956 | 2.17M |
| 50 | FOLD | Amicus Therapeutics, Inc. | 4.45B | 0.42% | 9,893,496 | 598.70M |
| 51 | ADMA | ADMA Biologics, Inc. | 4.35B | 3.28% | 1,709,791 | 488.56M |
| 52 | TGTX | TG Therapeutics, Inc. | 4.32B | 5.99% | 8,728,082 | 531.90M |
| 53 | LEGN | Legend Biotech Corporation | 4.30B | 3.15% | 1,757,022 | 909.05M |
| 54 | TERN | Terns Pharmaceuticals, Inc. | 4.04B | 7.92% | 3,859,655 | - |
| 55 | ACLX | Arcellx, Inc. | 4.04B | 4.66% | 854,225 | 35.90M |
| 56 | CORT | Corcept Therapeutics Incorporated | 3.90B | 1.90% | 1,284,936 | 741.17M |
| 57 | VKTX | Viking Therapeutics, Inc. | 3.88B | 11.89% | 6,880,238 | - |
| 58 | LGND | Ligand Pharmaceuticals Incorporated | 3.87B | 4.11% | 305,250 | 251.23M |
| 59 | NAMS | NewAmsterdam Pharma Company N.V. | 3.62B | 0.19% | 807,017 | 35.24M |
| 60 | BEAM | Beam Therapeutics Inc. | 3.49B | 2.49% | 2,340,451 | 55.70M |
| 61 | LQDA | Liquidia Corporation | 3.48B | 4.99% | 2,430,071 | 69.22M |
| 62 | VERA | Vera Therapeutics, Inc. | 3.44B | -1.41% | 1,260,417 | - |
| 63 | ARQT | Arcutis Biotherapeutics, Inc. | 3.27B | 2.61% | 1,288,958 | 317.93M |
| 64 | IDYA | IDEAYA Biosciences, Inc. | 3.25B | 5.53% | 1,542,803 | 214.83M |
| 65 | CNTA | Centessa Pharmaceuticals plc | 3.23B | -0.59% | 679,065 | 15.00M |
| 66 | VRDN | Viridian Therapeutics, Inc. | 3.22B | 5.60% | 1,561,349 | 70.79M |
| 67 | XENE | Xenon Pharmaceuticals Inc. | 3.21B | 3.02% | 1,196,847 | 7.50M |
| 68 | TARS | Tarsus Pharmaceuticals, Inc. | 3.19B | -0.66% | 286,690 | 366.10M |
| 69 | RCUS | Arcus Biosciences, Inc. | 3.04B | 8.00% | 2,093,393 | 240.00M |
| 70 | ALMS | Alumis Inc. | 3.03B | 10.09% | 4,066,536 | 22.12M |
| 71 | EWTX | Edgewise Therapeutics, Inc. | 2.98B | 12.91% | 2,390,675 | - |
| 72 | IBRX | ImmunityBio, Inc. | 2.97B | 7.09% | 45,524,662 | 82.56M |
| 73 | IRON | Disc Medicine, Inc. | 2.91B | 2.17% | 730,071 | - |
| 74 | DYN | Dyne Therapeutics, Inc. | 2.87B | 2.41% | 3,621,381 | - |
| 75 | DNLI | Denali Therapeutics Inc. | 2.85B | 0.88% | 1,128,479 | - |
| 76 | CPRX | Catalyst Pharmaceuticals, Inc. | 2.85B | 3.67% | 1,888,747 | 578.20M |
| 77 | ADPT | Adaptive Biotechnologies Corporation | 2.75B | -0.17% | 1,865,964 | 252.75M |
| 78 | WVE | Wave Life Sciences Ltd. | 2.66B | 2.04% | 6,073,199 | 109.23M |
| 79 | MLYS | Mineralys Therapeutics, Inc. | 2.64B | 1.44% | 1,394,509 | - |
| 80 | TVTX | Travere Therapeutics, Inc. | 2.59B | -0.62% | 4,372,120 | 435.83M |
| 81 | SYRE | Spyre Therapeutics, Inc. | 2.57B | 5.17% | 1,036,111 | - |
| 82 | AAPG | Ascentage Pharma Group International | 2.57B | 1.98% | 1,992 | 54.52M |
| 83 | APLS | Apellis Pharmaceuticals, Inc. | 2.57B | -4.69% | 5,580,136 | 1.02B |
| 84 | RXRX | Recursion Pharmaceuticals, Inc. | 2.52B | 3.41% | 16,919,382 | 43.69M |
| 85 | TLX | Telix Pharmaceuticals Limited | 2.51B | 2.28% | 280,317 | 664.23M |
| 86 | SRPT | Sarepta Therapeutics, Inc. | 2.39B | 6.24% | 3,133,760 | 2.41B |
| 87 | OCUL | Ocular Therapeutix, Inc. | 2.36B | 6.14% | 7,101,628 | 55.78M |
| 88 | ERAS | Erasca, Inc. | 2.36B | 10.73% | 11,279,332 | - |
| 89 | RARE | Ultragenyx Pharmaceutical Inc. | 2.32B | -0.08% | 2,264,664 | 630.60M |
| 90 | MESO | Mesoblast Limited | 2.30B | -0.68% | 181,011 | 17.20M |
| 91 | IMNM | Immunome, Inc. | 2.29B | 3.08% | 2,824,126 | 9.68M |
| 92 | SLNO | Soleno Therapeutics, Inc. | 2.28B | 2.29% | 2,214,500 | 98.68M |
| 93 | OLMA | Olema Pharmaceuticals, Inc. | 2.26B | 3.16% | 1,326,768 | - |
| 94 | GLPG | Galapagos NV | 2.19B | 2.62% | 223,164 | 336.64M |
| 95 | ZLAB | Zai Lab Limited | 2.18B | 4.75% | 1,035,361 | 441.63M |
| 96 | NUVB | Nuvation Bio Inc. | 2.16B | -3.66% | 7,260,231 | 26.75M |
| 97 | HRMY | Harmony Biosciences Holdings, Inc. | 2.08B | 0.78% | 924,497 | 825.94M |
| 98 | AUPH | Aurinia Pharmaceuticals Inc. | 2.01B | 1.60% | 867,533 | 265.81M |
| 99 | DNTH | Dianthus Therapeutics, Inc. | 1.98B | 3.19% | 1,235,664 | 3.08M |
| 100 | MAZE | Maze Therapeutics, Inc. | 1.98B | -0.68% | 531,182 | 2.50M |
| 101 | MBX | MBX Biosciences, Inc. | 1.93B | 18.40% | 1,425,060 | - |
| 102 | NRIX | Nurix Therapeutics, Inc. | 1.93B | 0.58% | 1,014,734 | 83.69M |
| 103 | GLUE | Monte Rosa Therapeutics, Inc. | 1.91B | 0.29% | 1,257,088 | 181.54M |
| 104 | VCEL | Vericel Corporation | 1.89B | 0.76% | 552,937 | 258.72M |
| 105 | SNDX | Syndax Pharmaceuticals, Inc. | 1.86B | 4.74% | 1,288,052 | 111.30M |
| 106 | ZYME | Zymeworks Inc. | 1.84B | 2.93% | 980,916 | 134.48M |
| 107 | SION | Sionna Therapeutics, Inc. | 1.84B | 11.87% | 268,909 | - |
| 108 | KOD | Kodiak Sciences Inc. | 1.78B | 1.24% | 927,025 | - |
| 109 | STOK | Stoke Therapeutics, Inc. | 1.77B | 1.28% | 587,966 | 205.63M |
| 110 | CLDX | Celldex Therapeutics, Inc. | 1.75B | 1.47% | 1,240,793 | 2.60M |
| 111 | UPB | Upstream Bio, Inc. | 1.75B | -0.92% | 620,693 | 2.80M |
| 112 | MNKD | MannKind Corporation | 1.72B | -0.53% | 2,592,769 | 313.79M |
| 113 | AGIO | Agios Pharmaceuticals, Inc. | 1.68B | 3.35% | 769,197 | 44.79M |
| 114 | ARDX | Ardelyx, Inc. | 1.67B | -2.13% | 3,270,786 | 398.23M |
| 115 | IMCR | Immunocore Holdings plc | 1.67B | 2.57% | 479,038 | 379.59M |
| 116 | TNGX | Tango Therapeutics, Inc. | 1.67B | 18.68% | 5,102,001 | 66.50M |
| 117 | PHVS | Pharvaris N.V. | 1.66B | -1.42% | 250,540 | - |
| 118 | NBY | NovaBay Pharmaceuticals, Inc. | 1.60B | -2.38% | 900,603 | 10.30M |
| 119 | PGEN | Precigen, Inc. | 1.56B | 5.76% | 3,608,783 | 6.31M |
| 120 | TYRA | Tyra Biosciences, Inc. | 1.56B | 1.35% | 298,276 | - |
| 121 | BHVN | Biohaven Ltd. | 1.55B | 6.65% | 3,209,826 | - |
| 122 | FTRE | Fortrea Holdings Inc. | 1.55B | -3.45% | 1,508,131 | 2.76B |
| 123 | ORKA | Oruka Therapeutics, Inc. | 1.55B | 2.11% | 274,122 | - |
| 124 | ELVN | Enliven Therapeutics, Inc. | 1.55B | 1.17% | 1,139,973 | - |
| 125 | MNMD | Mind Medicine (MindMed) Inc. | 1.48B | 1.01% | 2,054,701 | - |
| 126 | INVA | Innoviva, Inc. | 1.48B | 1.18% | 580,252 | 388.52M |
| 127 | TRVI | Trevi Therapeutics, Inc. | 1.47B | 1.33% | 1,315,002 | - |
| 128 | SVRA | Savara Inc. | 1.45B | 1.35% | 1,557,701 | - |
| 129 | RLAY | Relay Therapeutics, Inc. | 1.40B | 1.64% | 1,148,768 | 8.36M |
| 130 | NTLA | Intellia Therapeutics, Inc. | 1.39B | 2.39% | 5,486,170 | 57.53M |
| 131 | QURE | uniQure N.V. | 1.39B | 3.95% | 1,443,053 | 15.75M |
| 132 | ANAB | AnaptysBio, Inc. | 1.39B | 4.44% | 579,911 | 169.47M |
| 133 | TSHA | Taysha Gene Therapies, Inc. | 1.38B | 2.86% | 2,321,946 | 6.31M |
| 134 | OCS | Oculis Holding AG | 1.37B | 2.69% | 217,057 | 992.00K |
| 135 | ATAI | AtaiBeckley Inc. | 1.35B | 1.36% | 4,225,299 | 3.02M |
| 136 | NVAX | Novavax, Inc. | 1.33B | -5.54% | 7,494,720 | 1.06B |
| 137 | EYPT | EyePoint, Inc. | 1.32B | -0.06% | 875,784 | 42.34M |
| 138 | IMTX | Immatics N.V. | 1.32B | 4.80% | 369,838 | 99.45M |
| 139 | RAPP | Rapport Therapeutics, Inc. | 1.31B | 1.18% | 319,568 | - |
| 140 | ABCL | AbCellera Biologics Inc. | 1.28B | 0.47% | 4,053,930 | 35.33M |
| 141 | CAPR | Capricor Therapeutics, Inc. | 1.28B | - | 1,068,787 | 11.13M |
| 142 | SANA | Sana Biotechnology, Inc. | 1.26B | 0.85% | 2,354,612 | - |
| 143 | XERS | Xeris Biopharma Holdings, Inc. | 1.26B | -1.69% | 1,283,652 | 266.14M |
| 144 | PHAR | Pharming Group N.V. | 1.26B | 3.88% | 28,584 | 362.27M |
| 145 | PVLA | Palvella Therapeutics, Inc. | 1.25B | 1.70% | 87,823 | - |
| 146 | MLTX | MoonLake Immunotherapeutics | 1.24B | 1.81% | 1,955,564 | - |
| 147 | ZBIO | Zenas BioPharma, Inc. | 1.21B | 4.59% | 766,303 | 15.00M |
| 148 | SEPN | Septerna, Inc. | 1.20B | 1.33% | 172,549 | 22.05M |
| 149 | PHAT | Phathom Pharmaceuticals, Inc. | 1.19B | -3.13% | 1,009,667 | 147.19M |
| 150 | SPRY | ARS Pharmaceuticals, Inc. | 1.17B | 4.24% | 1,336,093 | 142.77M |
| 151 | IVA | Inventiva S.A. | 1.13B | 4.73% | 1,143,824 | 19.93M |
| 152 | INBX | Inhibrx Biosciences, Inc. | 1.10B | 3.62% | 116,711 | 1.40M |
| 153 | DAWN | Day One Biopharmaceuticals, Inc. | 1.10B | 1.32% | 2,054,920 | 133.67M |
| 154 | ORIC | ORIC Pharmaceuticals, Inc. | 1.10B | 10.95% | 5,033,812 | - |
| 155 | AKTS | Aktis Oncology, Inc. | 1.09B | -2.53% | 569,368 | 5.56M |
| 156 | CMPX | Compass Therapeutics, Inc. | 1.07B | 8.24% | 6,447,573 | 850.00K |
| 157 | GHRS | GH Research PLC | 1.05B | 6.76% | 344,373 | - |
| 158 | TBPH | Theravance Biopharma, Inc. | 1.04B | 1.38% | 306,880 | 80.33M |
| 159 | XNCR | Xencor, Inc. | 1.03B | 3.66% | 560,215 | 150.13M |
| 160 | NBTX | Nanobiotix S.A. | 1.03B | 0.70% | 15,344 | 11.93M |
| 161 | MRVI | Maravai LifeSciences Holdings, Inc. | 1.01B | -1.99% | 632,433 | 192.44M |
| 162 | ANNX | Annexon, Inc. | 995.69M | 7.92% | 4,643,449 | - |
| 163 | VTYX | Ventyx Biosciences, Inc. | 994.46M | - | 2,373,963 | - |
| 164 | BCAX | Bicara Therapeutics Inc. | 987.17M | 2.80% | 454,881 | - |
| 165 | BBOT | BridgeBio Oncology Therapeutics, Inc. | 963.06M | 4.60% | 101,189 | - |
| 166 | RAPT | RAPT Therapeutics, Inc. | 962.40M | 1.97% | 137,239 | - |
| 167 | VIR | Vir Biotechnology, Inc. | 948.83M | 8.08% | 2,892,991 | 16.86M |
| 168 | IOVA | Iovance Biotherapeutics, Inc. | 944.78M | 1.28% | 7,561,497 | 250.43M |
| 169 | AVBP | ArriVent BioPharma, Inc. | 927.59M | 2.28% | 326,832 | - |
| 170 | OMER | Omeros Corporation | 927.38M | 3.65% | 1,875,342 | - |
| 171 | ABUS | Arbutus Biopharma Corporation | 919.31M | 0.84% | 707,741 | 14.61M |
| 172 | VALN | Valneva SE | 892.29M | 3.34% | 9,329 | 211.09M |
| 173 | DRUG | Bright Minds Biosciences Inc. | 890.34M | 0.40% | 94,384 | - |
| 174 | URGN | UroGen Pharma Ltd. | 877.20M | -5.50% | 1,490,995 | 96.52M |
| 175 | GERN | Geron Corporation | 861.78M | 3.05% | 10,271,484 | 183.40M |
| 176 | JANX | Janux Therapeutics, Inc. | 849.29M | 2.39% | 1,206,841 | 10.00M |
| 177 | MDXG | MiMedx Group, Inc. | 842.70M | -3.23% | 2,475,639 | 393.44M |
| 178 | YDES | YD Bio Limited | 829.77M | -0.17% | 13,063 | 510.36K |
| 179 | MPLT | MapLight Therapeutics, Inc. | 818.71M | 6.35% | 202,097 | - |
| 180 | KURA | Kura Oncology, Inc. | 814.48M | 1.63% | 898,899 | 104.03M |
| 181 | ARVN | Arvinas, Inc. | 783.54M | -0.73% | 1,825,122 | 312.30M |
| 182 | KALV | KalVista Pharmaceuticals, Inc. | 770.33M | 2.01% | 2,191,513 | 1.43M |
| 183 | PRME | Prime Medicine, Inc. | 763.03M | 3.61% | 4,252,778 | 5.98M |
| 184 | RGNX | REGENXBIO Inc. | 756.82M | -0.66% | 531,177 | 161.32M |
| 185 | TENX | Tenax Therapeutics, Inc. | 741.22M | 21.40% | 1,284,592 | - |
| 186 | NKTR | Nektar Therapeutics | 734.13M | -1.34% | 609,095 | 62.60M |
| 187 | IVVD | Invivyd, Inc. | 733.17M | 11.11% | 4,539,334 | 50.04M |
| 188 | CTMX | CytomX Therapeutics, Inc. | 728.57M | 5.13% | 3,995,829 | 113.63M |
| 189 | ATXS | Astria Therapeutics, Inc. | 715.84M | 0.24% | 493,767 | 706.00K |
| 190 | DBVT | DBV Technologies S.A. | 713.07M | 1.82% | 334,140 | 5.50M |
| 191 | RIGL | Rigel Pharmaceuticals, Inc. | 710.08M | 3.06% | 368,033 | 282.08M |
| 192 | SLS | SELLAS Life Sciences Group, Inc. | 699.86M | -0.96% | 7,875,208 | - |
| 193 | GYRE | Gyre Therapeutics, Inc. | 698.95M | -1.28% | 37,838 | 107.27M |
| 194 | PROK | ProKidney Corp. | 685.90M | -0.44% | 510,914 | 744.00K |
| 195 | FULC | Fulcrum Therapeutics, Inc. | 683.45M | 1.07% | 726,054 | 80.00M |
| 196 | JBIO | Jade Biosciences, Inc. | 674.42M | 6.23% | 160,246 | - |
| 197 | EVMN | Evommune, Inc. | 669.89M | 1.48% | 142,213 | 13.00M |
| 198 | CGEM | Cullinan Therapeutics, Inc. | 642.16M | 1.30% | 585,285 | - |
| 199 | DRTS | Alpha Tau Medical Ltd. | 639.48M | 14.33% | 1,067,121 | - |
| 200 | ENGN | enGene Holdings Inc. | 609.56M | 8.59% | 693,867 | - |
| 201 | REPL | Replimune Group, Inc. | 604.80M | -4.10% | 990,869 | - |
| 202 | MGTX | MeiraGTx Holdings plc | 599.66M | 0.95% | 211,822 | 27.42M |
| 203 | KROS | Keros Therapeutics, Inc. | 595.00M | 0.15% | 325,098 | 246.72M |
| 204 | GOSS | Gossamer Bio, Inc. | 590.21M | -4.14% | 3,506,610 | 44.05M |
| 205 | OCGN | Ocugen, Inc. | 587.16M | -1.57% | 7,050,530 | 5.37M |
| 206 | LENZ | LENZ Therapeutics, Inc. | 581.68M | 11.99% | 1,815,009 | 17.50M |
| 207 | FBRX | Forte Biosciences, Inc. | 572.21M | -1.23% | 101,272 | - |
| 208 | VOR | Vor Biopharma Inc. | 571.90M | 9.49% | 1,108,685 | - |
| 209 | LXEO | Lexeo Therapeutics, Inc. | 563.46M | 3.90% | 979,531 | - |
| 210 | DNA | Ginkgo Bioworks Holdings, Inc. | 559.84M | 2.39% | 694,307 | 180.61M |
| 211 | CRMD | CorMedix Inc. | 558.61M | 0.42% | 3,733,355 | 214.30M |
| 212 | DSGN | Design Therapeutics, Inc. | 558.24M | 2.40% | 124,941 | - |
| 213 | ANRO | Alto Neuroscience, Inc. | 533.10M | 4.00% | 160,767 | - |
| 214 | VSTM | Verastem, Inc. | 524.06M | -5.69% | 1,971,183 | 13.38M |
| 215 | KYTX | Kyverna Therapeutics, Inc. | 523.31M | 5.77% | 1,411,596 | - |
| 216 | ZVRA | Zevra Therapeutics, Inc. | 516.25M | 2.80% | 1,090,860 | 84.39M |
| 217 | CRVS | Corvus Pharmaceuticals, Inc. | 509.33M | 4.92% | 720,190 | - |
| 218 | ASMB | Assembly Biosciences, Inc. | 506.78M | 1.39% | 36,352 | 37.19M |
| 219 | NAGE | Niagen Bioscience, Inc. | 505.36M | -2.92% | 913,960 | 124.71M |
| 220 | ABSI | Absci Corporation | 503.74M | 1.21% | 2,568,069 | 2.82M |
| 221 | FDMT | 4D Molecular Therapeutics, Inc. | 500.50M | 11.45% | 973,818 | 120.00K |
| 222 | LYEL | Lyell Immunopharma, Inc. | 498.38M | -1.05% | 66,232 | 41.00K |
| 223 | VTVT | vTv Therapeutics Inc. | 496.48M | 7.21% | 68,791 | 17.00K |
| 224 | PRTA | Prothena Corporation plc | 494.70M | 2.34% | 398,427 | 11.79M |
| 225 | LBRX | LB Pharmaceuticals Inc | 489.79M | -2.17% | 256,133 | - |
| 226 | MNPR | Monopar Therapeutics Inc. | 465.11M | 3.82% | 255,107 | - |
| 227 | DMAC | DiaMedica Therapeutics Inc. | 460.77M | 4.24% | 120,161 | - |
| 228 | ADCT | ADC Therapeutics SA | 459.58M | 0.27% | 553,180 | 75.21M |
| 229 | BCYC | Bicycle Therapeutics plc | 459.22M | 2.00% | 198,729 | 28.34M |
| 230 | ALT | Altimmune, Inc. | 456.27M | 4.24% | 3,263,309 | 20.00K |
| 231 | VNDA | Vanda Pharmaceuticals Inc. | 455.04M | 3.49% | 904,844 | 212.07M |
| 232 | IMMP | Immutep Limited | 453.24M | -0.64% | 142,102 | 3.31M |
| 233 | SLDB | Solid Biosciences Inc. | 452.66M | 12.60% | 1,970,009 | - |
| 234 | LXRX | Lexicon Pharmaceuticals, Inc. | 450.61M | 3.33% | 1,590,393 | 70.86M |
| 235 | PRTC | PureTech Health plc | 438.83M | 4.81% | 3,352 | 6.39M |
| 236 | AVXL | Anavex Life Sciences Corp. | 430.66M | 3.88% | 2,134,767 | - |
| 237 | CTNM | Contineum Therapeutics, Inc. | 429.59M | 7.89% | 411,611 | - |
| 238 | RCKT | Rocket Pharmaceuticals, Inc. | 428.56M | 4.21% | 2,589,050 | - |
| 239 | EPRX | Eupraxia Pharmaceuticals Inc. | 421.43M | 1.44% | 83,493 | - |
| 240 | LCTX | Lineage Cell Therapeutics, Inc. | 411.96M | 1.80% | 788,587 | 10.82M |
| 241 | BNTC | Benitec Biopharma Inc. | 410.75M | -1.38% | 106,638 | - |
| 242 | NBP | NovaBridge Biosciences | 406.98M | -3.29% | 820,749 | - |
| 243 | HELP | Cybin Inc. | 406.22M | 5.30% | 776,958 | - |
| 244 | GLSI | Greenwich LifeSciences, Inc. | 405.80M | 0.93% | 646,108 | - |
| 245 | ENTA | Enanta Pharmaceuticals, Inc. | 399.46M | 5.41% | 221,772 | 65.32M |
| 246 | ALLO | Allogene Therapeutics, Inc. | 382.04M | 3.66% | 4,626,865 | 22.00K |
| 247 | TRDA | Entrada Therapeutics, Inc. | 379.42M | 1.15% | 298,169 | 61.52M |
| 248 | AUTL | Autolus Therapeutics plc | 377.92M | 3.65% | 2,839,029 | 51.13M |
| 249 | FHTX | Foghorn Therapeutics Inc. | 369.65M | -5.54% | 434,775 | 24.52M |
| 250 | TECX | Tectonic Therapeutic, Inc. | 368.15M | -0.41% | 133,797 | - |
| 251 | NMRA | Neumora Therapeutics, Inc. | 365.37M | 0.47% | 621,060 | - |
| 252 | XOMA | XOMA Royalty Corporation | 363.57M | 8.18% | 1,298,433 | 47.11M |
| 253 | ACIU | AC Immune SA | 363.12M | -0.81% | 526,860 | 5.48M |
| 254 | PEPG | PepGen Inc. | 354.05M | -8.04% | 590,858 | - |
| 255 | ZURA | Zura Bio Limited | 349.18M | 4.07% | 237,157 | - |
| 256 | CADL | Candel Therapeutics, Inc. | 340.92M | 1.31% | 1,306,690 | - |
| 257 | AURA | Aura Biosciences, Inc. | 334.03M | 3.95% | 163,225 | - |
| 258 | XFOR | X4 Pharmaceuticals, Inc. | 329.64M | -2.58% | 311,755 | 33.98M |
| 259 | AARD | Aardvark Therapeutics, Inc. | 326.16M | -2.66% | 253,788 | - |
| 260 | PBYI | Puma Biotechnology, Inc. | 323.51M | 2.88% | 351,194 | 212.00M |
| 261 | CAMP | Camp4 Therapeutics Corporation | 307.14M | -2.31% | 73,635 | 3.80M |
| 262 | AVTX | Avalo Therapeutics, Inc. | 299.72M | -5.87% | 570,717 | 192.00K |
| 263 | STTK | Shattuck Labs, Inc. | 299.31M | 4.88% | 416,179 | 1.00M |
| 264 | ACHV | Achieve Life Sciences, Inc. | 298.64M | 1.63% | 358,066 | - |
| 265 | CLLS | Cellectis S.A. | 298.37M | 0.47% | 68,990 | 82.55M |
| 266 | ACRS | Aclaris Therapeutics, Inc. | 296.87M | 1.11% | 352,270 | 15.74M |
| 267 | LRMR | Larimar Therapeutics, Inc. | 291.86M | 2.40% | 1,617,549 | - |
| 268 | NGNE | Neurogene Inc. | 291.21M | 10.91% | 131,107 | 925.00K |
| 269 | PALI | Palisade Bio, Inc. | 290.56M | 3.17% | 4,120,077 | - |
| 270 | IMRX | Immuneering Corporation | 286.04M | 7.13% | 2,257,850 | - |
| 271 | RLMD | Relmada Therapeutics, Inc. | 281.60M | -5.42% | 413,756 | - |
| 272 | ABEO | Abeona Therapeutics Inc. | 281.25M | 1.96% | 718,825 | 400.00K |
| 273 | SLN | Silence Therapeutics plc | 277.26M | -0.68% | 372,987 | 25.83M |
| 274 | AVIR | Atea Pharmaceuticals, Inc. | 276.57M | 0.85% | 204,907 | - |
| 275 | GUTS | Fractyl Health, Inc. | 275.46M | - | 2,181,193 | 3.00K |
| 276 | OABI | OmniAb, Inc. | 274.95M | 0.53% | 238,409 | 21.09M |
| 277 | HRTX | Heron Therapeutics, Inc. | 273.21M | 0.68% | 656,301 | 155.10M |
| 278 | TARA | Protara Therapeutics, Inc. | 264.72M | 0.41% | 1,337,890 | - |
| 279 | MENS | Jyong Biotech Ltd. | 263.77M | -2.00% | 314,574 | - |
| 280 | IMMX | Immix Biopharma, Inc. | 261.37M | 9.73% | 720,317 | - |
| 281 | FENC | Fennec Pharmaceuticals Inc. | 259.23M | 0.13% | 396,671 | 38.79M |
| 282 | ALDX | Aldeyra Therapeutics, Inc. | 255.09M | 2.42% | 593,883 | - |
| 283 | RZLT | Rezolute, Inc. | 252.22M | 9.68% | 7,182,969 | - |
| 284 | OBIO | Orchestra BioMed Holdings, Inc. | 251.83M | 4.21% | 181,946 | 2.82M |
| 285 | CBIO | Crescent Biopharma, Inc. | 246.91M | 14.30% | 118,013 | - |
| 286 | NAUT | Nautilus Biotechnology, Inc. | 242.51M | -2.04% | 325,740 | - |
| 287 | IKT | Inhibikase Therapeutics, Inc. | 232.53M | 1.19% | 185,757 | 1.00 |
| 288 | VYGR | Voyager Therapeutics, Inc. | 229.63M | 2.74% | 1,733,625 | 31.32M |
| 289 | ENLV | Enlivex Therapeutics Ltd. | 229.43M | 9.26% | 559,439 | - |
| 290 | ZNTL | Zentalis Pharmaceuticals, Inc. | 227.28M | 0.86% | 1,098,253 | 26.87M |
| 291 | CCCC | C4 Therapeutics, Inc. | 225.81M | 0.87% | 1,031,953 | 30.11M |
| 292 | HUMA | Humacyte, Inc. | 220.02M | 2.70% | 3,506,846 | 1.57M |
| 293 | ARCT | Arcturus Therapeutics Holdings Inc. | 219.64M | 2.11% | 627,499 | 97.60M |
| 294 | MDWD | MediWound Ltd. | 218.48M | 3.27% | 120,691 | 20.93M |
| 295 | EDIT | Editas Medicine, Inc. | 216.71M | 6.22% | 2,919,881 | 46.38M |
| 296 | NVCT | Nuvectis Pharma, Inc. | 215.42M | 1.20% | 39,880 | - |
| 297 | OVID | Ovid Therapeutics Inc. | 214.80M | - | 709,306 | 6.61M |
| 298 | TNXP | Tonix Pharmaceuticals Holding Corp. | 209.42M | 8.13% | 749,619 | 10.30M |
| 299 | ARMP | Armata Pharmaceuticals, Inc. | 207.52M | -10.24% | 69,126 | 5.05M |
| 300 | SGMT | Sagimet Biosciences Inc. | 207.16M | 2.58% | 697,567 | - |
| 301 | CABA | Cabaletta Bio, Inc. | 206.97M | - | 946,967 | - |
| 302 | MIST | Milestone Pharmaceuticals Inc. | 206.21M | 5.18% | 4,044,239 | - |
| 303 | ALEC | Alector, Inc. | 201.93M | -3.65% | 1,285,562 | 69.05M |
| 304 | RNAC | Cartesian Therapeutics, Inc. | 198.67M | -0.26% | 96,407 | 1.09M |
| 305 | GALT | Galectin Therapeutics Inc. | 193.42M | -2.28% | 387,777 | - |
| 306 | CHRS | Coherus Oncology, Inc. | 193.39M | -5.88% | 870,835 | 277.73M |
| 307 | SABS | SAB Biotherapeutics, Inc. | 190.43M | 1.52% | 779,263 | 114.70K |
| 308 | CRDF | Cardiff Oncology, Inc. | 189.28M | -2.09% | 571,958 | 501.00K |
| 309 | CLYM | Climb Bio, Inc. | 189.07M | -4.12% | 555,478 | - |
| 310 | SLGL | Sol-Gel Technologies Ltd. | 188.85M | 7.71% | 15,854 | 18.97M |
| 311 | NERV | Minerva Neurosciences, Inc. | 186.51M | 0.94% | 50,502 | - |
| 312 | PRLD | Prelude Therapeutics Incorporated | 186.22M | 0.89% | 317,806 | 10.50M |
| 313 | CGEN | Compugen Ltd. | 185.20M | 0.51% | 587,653 | 6.90M |
| 314 | NTHI | NeOnc Technologies Holdings, Inc. | 181.89M | -2.51% | 59,618 | 59.99K |
| 315 | IPSC | Century Therapeutics, Inc. | 176.37M | -6.05% | 2,373,471 | 113.34M |
| 316 | TLSA | Tiziana Life Sciences Ltd | 174.67M | 8.89% | 352,597 | - |
| 317 | KLRS | Kalaris Therapeutics, Inc. | 172.81M | - | 45,315 | - |
| 318 | PRQR | ProQR Therapeutics N.V. | 172.77M | - | 611,107 | 18.86M |
| 319 | SRZN | Surrozen, Inc. | 171.43M | -3.15% | 41,863 | 3.60M |
| 320 | RANI | Rani Therapeutics Holdings, Inc. | 170.13M | -1.41% | 1,136,745 | 1.20M |
| 321 | QNCX | Quince Therapeutics, Inc. | 167.60M | - | 994,288 | - |
| 322 | PLX | Protalix BioTherapeutics, Inc. | 165.67M | 1.98% | 544,596 | 61.84M |
| 323 | TNYA | Tenaya Therapeutics, Inc. | 163.98M | -0.21% | 2,382,412 | - |
| 324 | IPHA | Innate Pharma S.A. | 162.21M | -3.15% | 34,652 | 14.84M |
| 325 | ELDN | Eledon Pharmaceuticals, Inc. | 161.09M | 3.05% | 781,173 | - |
| 326 | CDXS | Codexis, Inc. | 160.78M | 4.09% | 559,175 | 52.93M |
| 327 | AGEN | Agenus Inc. | 159.16M | 1.52% | 1,229,415 | 106.83M |
| 328 | BDTX | Black Diamond Therapeutics, Inc. | 158.96M | 1.45% | 905,002 | 70.00M |
| 329 | MOLN | Molecular Partners AG | 155.88M | 2.42% | 2,743 | 856.30K |
| 330 | CRBP | Corbus Pharmaceuticals Holdings, Inc. | 153.05M | 4.03% | 251,739 | - |
| 331 | CRBU | Caribou Biosciences, Inc. | 150.48M | 1.26% | 722,963 | 9.30M |
| 332 | IRD | Opus Genetics, Inc. | 149.65M | 1.40% | 364,366 | 14.63M |
| 333 | NKTX | Nkarta, Inc. | 147.03M | 0.98% | 544,826 | - |
| 334 | SGMO | Sangamo Therapeutics, Inc. | 145.70M | -3.43% | 2,121,362 | 32.88M |
| 335 | MCRB | Seres Therapeutics, Inc. | 145.47M | 0.69% | 66,705 | 351.00K |
| 336 | ORMP | Oramed Pharmaceuticals Inc. | 144.88M | 7.37% | 1,534,205 | 2.00M |
| 337 | CNTX | Context Therapeutics Inc. | 144.25M | 4.67% | 1,489,307 | - |
| 338 | UNCY | Unicycive Therapeutics, Inc. | 142.06M | 9.62% | 905,079 | - |
| 339 | SPRO | Spero Therapeutics, Inc. | 141.41M | 2.45% | 215,188 | 40.55M |
| 340 | ELTX | Elicio Therapeutics, Inc. | 141.20M | 3.99% | 48,389 | - |
| 341 | TTRX | Turn Therapeutics Inc. | 139.57M | -2.87% | 143,726 | - |
| 342 | WHWK | Whitehawk Therapeutics, Inc. | 136.67M | 5.45% | 333,369 | 14.38M |
| 343 | VXRT | Vaxart, Inc. | 131.99M | 3.75% | - | 148.20M |
| 344 | KPTI | Karyopharm Therapeutics Inc. | 131.65M | -9.10% | 742,992 | 142.53M |
| 345 | ACOG | Alpha Cognition Inc. | 128.93M | -1.50% | 57,836 | 7.43M |
| 346 | VRCA | Verrica Pharmaceuticals Inc. | 127.12M | -0.87% | 79,997 | 30.83M |
| 347 | CGTX | Cognition Therapeutics, Inc. | 125.35M | -0.70% | 428,226 | - |
| 348 | FATE | Fate Therapeutics, Inc. | 124.58M | 5.88% | 1,494,123 | 7.14M |
| 349 | PYXS | Pyxis Oncology, Inc. | 123.91M | 5.85% | 1,043,407 | 2.82M |
| 350 | ACTU | Actuate Therapeutics, Inc. | 122.26M | -4.71% | 67,135 | - |
| 351 | CNTB | Connect Biopharma Holdings Limited | 121.87M | - | 36,757 | 762.00K |
| 352 | ARTV | Artiva Biotherapeutics, Inc. | 117.32M | 3.91% | 160,098 | 251.00K |
| 353 | GNLX | Genelux Corporation | 115.58M | -4.74% | 371,740 | 8.00K |
| 354 | BMEA | Biomea Fusion, Inc. | 114.54M | 6.58% | 2,370,826 | - |
| 355 | MREO | Mereo BioPharma Group plc | 114.03M | 8.58% | 28,645,990 | 500.00K |
| 356 | ONCY | Oncolytics Biotech Inc. | 112.99M | 5.00% | 912,685 | - |
| 357 | INO | Inovio Pharmaceuticals, Inc. | 112.67M | 2.50% | 1,194,119 | 182.34K |
| 358 | MGNX | MacroGenics, Inc. | 112.60M | 1.71% | 460,731 | 127.63M |
| 359 | RPTX | Repare Therapeutics Inc. | 112.08M | 0.58% | 424,740 | 11.87M |
| 360 | THAR | Tharimmune, Inc. | 111.52M | 5.88% | 303,634 | - |
| 361 | ANIX | Anixa Biosciences, Inc. | 110.47M | 0.91% | 151,645 | - |
| 362 | ABOS | Acumen Pharmaceuticals, Inc. | 108.43M | 3.47% | 221,140 | - |
| 363 | SEER | Seer, Inc. | 108.00M | 0.52% | 73,870 | 16.38M |
| 364 | STRO | Sutro Biopharma, Inc. | 107.86M | 19.10% | 243,885 | 105.65M |
| 365 | OKYO | OKYO Pharma Limited | 106.44M | -9.00% | 260,342 | - |
| 366 | CBUS | Cibus, Inc. | 105.73M | -3.94% | 194,945 | 3.79M |
| 367 | SAVA | Cassava Sciences, Inc. | 103.86M | 4.88% | 754,176 | - |
| 368 | ETHZ | ETHZilla Corporation | 102.86M | 5.05% | 863,913 | 4.11M |
| 369 | FBIO | Fortress Biotech, Inc. | 101.80M | -15.90% | 2,624,974 | 62.30M |
| 370 | CSBR | Champions Oncology, Inc. | 100.51M | 2.59% | 5,637 | 58.42M |
| 371 | HYFT | MindWalk Holdings Corp. | 99.92M | -12.30% | 981,797 | 19.02M |
| 372 | DTIL | Precision BioSciences, Inc. | 99.42M | 0.49% | 176,872 | 698.00K |
| 373 | COYA | Coya Therapeutics, Inc. | 97.09M | 0.43% | 279,123 | 3.99M |
| 374 | VANI | Vivani Medical, Inc. | 92.65M | -0.78% | 72,890 | - |
| 375 | EXOZ | eXoZymes, Inc. | 88.90M | 3.92% | 10,105 | -700.00 |
| 376 | DWTX | Dogwood Therapeutics, Inc. | 86.21M | 8.61% | 76,867 | - |
| 377 | ADAG | Adagene Inc. | 84.84M | 5.88% | 45,638 | 103.20K |
| 378 | KRRO | Korro Bio, Inc. | 84.76M | 0.11% | 92,196 | 7.37M |
| 379 | GANX | Gain Therapeutics, Inc. | 84.62M | -1.35% | 525,388 | - |
| 380 | ANVS | Annovis Bio, Inc. | 84.01M | 1.60% | 558,707 | - |
| 381 | SPRB | Spruce Biosciences, Inc. | 83.88M | -3.84% | 45,175 | 697.00K |
| 382 | ACET | Adicet Bio, Inc. | 83.78M | - | 92,876 | - |
| 383 | PLRX | Pliant Therapeutics, Inc. | 80.50M | 1.55% | 825,391 | - |
| 384 | COEP | Coeptis Therapeutics Holdings, Inc. | 80.26M | -1.74% | 26,230 | 501.00K |
| 385 | XBIT | XBiotech Inc. | 79.57M | 1.95% | 48,751 | - |
| 386 | CALC | CalciMedica, Inc. | 78.82M | -1.44% | 46,221 | - |
| 387 | IMUX | Immunic, Inc. | 78.19M | -4.03% | 1,778,203 | - |
| 388 | ATOS | Atossa Therapeutics, Inc. | 77.76M | -5.30% | 1,631,246 | - |
| 389 | PTHS | Pelthos Therapeutics Inc. | 77.48M | -0.46% | 7,148 | 7.41M |
| 390 | ENTX | Entera Bio Ltd. | 74.75M | 11.64% | 828,937 | 124.00K |
| 391 | KZIA | Kazia Therapeutics Limited | 74.53M | 8.57% | 305,848 | 1.20M |
| 392 | IMA | ImageneBio, Inc. | 72.75M | 0.89% | 12,742 | 800.00K |
| 393 | IFRX | InflaRx N.V. | 72.49M | 7.00% | 686,822 | 73.73K |
| 394 | PYPD | PolyPid Ltd. | 72.19M | -1.59% | 75,417 | - |
| 395 | ALXO | ALX Oncology Holdings Inc. | 72.11M | -10.74% | 282,441 | - |
| 396 | MNOV | MediciNova, Inc. | 70.77M | -0.69% | 34,077 | 257.92K |
| 397 | EQ | Equillium, Inc. | 70.64M | 5.45% | 317,211 | 4.39M |
| 398 | ATYR | aTyr Pharma, Inc. | 70.34M | 1.67% | 1,032,946 | 190.00K |
| 399 | BYSI | BeyondSpring Inc. | 68.67M | 2.45% | 16,019 | 1.88M |
| 400 | TCRX | TScan Therapeutics, Inc. | 68.10M | 2.56% | 486,285 | 8.42M |
| 401 | MGX | Metagenomi Therapeutics, Inc. | 64.96M | 0.58% | 334,185 | 30.91M |
| 402 | CRVO | CervoMed Inc. | 64.68M | -7.29% | 92,617 | 6.16M |
| 403 | NRXP | NRx Pharmaceuticals, Inc. | 63.65M | 0.94% | 21,983,700 | 242.00K |
| 404 | TVGN | Tevogen Bio Holdings Inc. | 63.16M | 1.31% | 515,170 | - |
| 405 | MAIA | MAIA Biotechnology, Inc. | 63.14M | 6.45% | 683,851 | - |
| 406 | ATHE | Alterity Therapeutics Limited | 61.71M | -0.88% | 5,977 | 3.57M |
| 407 | LPCN | Lipocine Inc. | 61.07M | 5.06% | 344,842 | 4.32M |
| 408 | PMVP | PMV Pharmaceuticals, Inc. | 60.66M | -1.72% | 341,568 | - |
| 409 | ICCC | ImmuCell Corporation | 59.88M | -0.45% | 3,513 | 27.77M |
| 410 | ANL | Adlai Nortye Ltd. | 59.41M | -2.42% | 66,626 | -1.35M |
| 411 | RADX | Radiopharm Theranostics Limited | 59.24M | 0.58% | 43,446 | 8.20M |
| 412 | ACRV | Acrivon Therapeutics, Inc. | 57.75M | 7.65% | 2,101,518 | - |
| 413 | LITS | Lite Strategy, Inc. | 56.99M | 4.03% | 820,470 | - |
| 414 | GRCE | Grace Therapeutics, Inc. | 56.33M | 2.82% | 14,215 | - |
| 415 | IBIO | iBio, Inc. | 55.99M | -1.97% | 1,988,958 | 500.00K |
| 416 | ALGS | Aligos Therapeutics, Inc. | 55.69M | -2.06% | 86,689 | 2.65M |
| 417 | INKT | MiNK Therapeutics, Inc. | 55.02M | -0.68% | 4,018 | - |
| 418 | OSTX | OS Therapies Incorporated | 54.58M | 0.65% | 1,635,617 | - |
| 419 | PDSB | PDS Biotechnology Corporation | 53.92M | 2.61% | 1,061,367 | - |
| 420 | NTRB | Nutriband Inc. | 51.66M | 0.24% | 5,730 | 2.28M |
| 421 | IBO | Impact BioMedical Inc. | 50.64M | 0.25% | 36,675 | 25.00K |
| 422 | NRXS | NeurAxis, Inc. | 50.49M | -3.66% | 84,918 | 3.36M |
| 423 | ABVC | ABVC BioPharma, Inc. | 49.03M | -0.95% | 58,592 | 797.92K |
| 424 | TIL | Instil Bio, Inc. | 48.76M | -0.14% | 87,021 | - |
| 425 | PASG | Passage Bio, Inc. | 48.19M | 6.24% | 40,051 | - |
| 426 | PTN | Palatin Technologies, Inc. | 47.18M | -2.27% | 53,912 | 8.85M |
| 427 | TELO | Telomir Pharmaceuticals, Inc. | 46.41M | 1.50% | 103,655 | - |
| 428 | HURA | TuHURA Biosciences, Inc. | 45.95M | 4.03% | 339,327 | - |
| 429 | ANEB | Anebulo Pharmaceuticals, Inc. | 45.60M | - | 19,054 | - |
| 430 | NXTC | NextCure, Inc. | 45.43M | -2.99% | 25,234 | - |
| 431 | JSPR | Jasper Therapeutics, Inc. | 45.33M | 3.85% | 796,604 | - |
| 432 | KZR | Kezar Life Sciences, Inc. | 45.18M | -0.64% | 2,936 | - |
| 433 | CVM | CEL-SCI Corporation | 44.31M | 3.74% | 47,372 | - |
| 434 | QTTB | Q32 Bio Inc. | 44.30M | 6.82% | 189,252 | - |
| 435 | ESLA | Estrella Immunopharma, Inc. | 43.72M | 9.46% | 55,199 | - |
| 436 | XLO | Xilio Therapeutics, Inc. | 43.62M | -1.52% | 224,886 | 31.80M |
| 437 | TVRD | Tvardi Therapeutics, Inc. | 43.44M | 1.54% | 68,906 | - |
| 438 | OKUR | OnKure Therapeutics, Inc. | 43.22M | 1.59% | 35,279 | - |
| 439 | APLM | Apollomics, Inc. | 42.54M | -4.30% | 15,243 | 6.93M |
| 440 | EVAX | Evaxion A/S | 42.20M | -0.78% | 54,035 | 7.65M |
| 441 | ATNM | Actinium Pharmaceuticals, Inc. | 41.49M | -1.48% | 72,656 | 90.00K |
| 442 | INMB | INmune Bio, Inc. | 40.94M | 2.67% | 229,464 | 50.00K |
| 443 | RVPH | Reviva Pharmaceuticals Holdings, Inc. | 40.90M | -1.41% | 2,908,482 | - |
| 444 | PSTV | Plus Therapeutics, Inc. | 39.91M | -38.23% | 94,804,612 | 5.26M |
| 445 | GLTO | Galecto, Inc. | 39.86M | 7.25% | 18,831 | - |
| 446 | LTRN | Lantern Pharma Inc. | 39.59M | 8.59% | 52,400 | - |
| 447 | RNXT | RenovoRx, Inc. | 38.85M | 1.44% | 194,979 | 928.00K |
| 448 | IOBT | IO Biotech, Inc. | 38.56M | 3.68% | 521,066 | - |
| 449 | CELU | Celularity Inc. | 38.35M | -1.48% | 5,913 | 40.58M |
| 450 | XCUR | Exicure, Inc. | 38.24M | 1.18% | 50,311 | 500.00K |
| 451 | GBIO | Generation Bio Co. | 38.13M | 0.36% | 30,288 | 15.27M |
| 452 | VERU | Veru Inc. | 37.56M | -2.90% | 65,141 | 16.89M |
| 453 | ANTX | AN2 Therapeutics, Inc. | 35.90M | 3.97% | 116,281 | - |
| 454 | CING | Cingulate Inc. | 35.63M | 0.81% | 61,989 | - |
| 455 | OTLK | Outlook Therapeutics, Inc. | 34.62M | -3.81% | 2,624,170 | 1.41M |
| 456 | SKYE | Skye Bioscience, Inc. | 32.70M | 4.08% | 448,944 | - |
| 457 | ATRA | Atara Biotherapeutics, Inc. | 32.23M | 2.29% | 870,541 | 151.93M |
| 458 | GNTA | Genenta Science S.p.A. | 32.10M | -3.52% | 59,793 | - |
| 459 | DYAI | Dyadic International, Inc. | 31.83M | 0.87% | 27,223 | 3.34M |
| 460 | NRSN | NeuroSense Therapeutics Ltd. | 31.78M | -1.83% | 68,729 | - |
| 461 | LIXT | Lixte Biotechnology Holdings, Inc. | 31.15M | 7.04% | 59,759 | - |
| 462 | CUE | Cue Biopharma, Inc. | 31.11M | -2.74% | 1,022,057 | 7.10M |
| 463 | BRNS | Barinthus Biotherapeutics plc | 30.82M | -0.61% | 54,961 | 14.97M |
| 464 | MRKR | Marker Therapeutics, Inc. | 30.35M | 6.43% | 514,655 | 4.69M |
| 465 | HYPD | Hyperion DeFi, Inc. | 29.81M | 6.93% | 269,741 | 345.32K |
| 466 | RNTX | Rein Therapeutics Inc. | 29.44M | -0.88% | 116,384 | - |
| 467 | DARE | Daré Bioscience, Inc. | 29.01M | 5.18% | 82,951 | -57.13K |
| 468 | RLYB | Rallybio Corporation | 28.95M | -2.79% | 161,683 | 674.00K |
| 469 | SNTI | Senti Biosciences, Inc. | 28.92M | 3.77% | 259,562 | - |
| 470 | IGC | IGC Pharma, Inc. | 28.72M | 0.13% | 249,088 | 1.11M |
| 471 | SER | Serina Therapeutics, Inc. | 28.47M | 8.54% | 73,211 | 116.00K |
| 472 | HOWL | Werewolf Therapeutics, Inc. | 28.36M | 2.26% | 581,286 | 1.14M |
| 473 | PLUR | Pluri Inc. | 28.32M | -5.15% | 1,191 | 1.33M |
| 474 | BOLD | Boundless Bio, Inc. | 28.20M | 1.61% | 75,522 | - |
| 475 | JUNS | Jupiter Neurosciences, Inc. | 27.89M | -12.43% | 161,891 | - |
| 476 | VTGN | Vistagen Therapeutics, Inc. | 27.71M | 2.32% | 1,853,418 | 721.00K |
| 477 | QNTM | Quantum BioPharma Ltd. | 27.24M | -5.65% | 47,369 | - |
| 478 | LONA | LeonaBio, Inc. | 25.95M | 0.61% | 44,699 | - |
| 479 | INTS | Intensity Therapeutics, Inc. | 25.53M | 1.70% | 1,761,177 | - |
| 480 | NNVC | NanoViricides, Inc. | 24.80M | -4.17% | 216,669 | - |
| 481 | PLRZ | Polyrizon Ltd. | 24.07M | 9.18% | 112,468 | - |
| 482 | FBLG | FibroBiologics, Inc. | 22.63M | 0.53% | 787,883 | - |
| 483 | LNAI | Lunai Bioworks Inc. | 22.54M | -0.98% | 215,540 | - |
| 484 | KLTO | Klotho Neurosciences, Inc. | 22.20M | -6.04% | 842,070 | - |
| 485 | NEUP | Neuphoria Therapeutics Inc. | 21.72M | -3.12% | 35,497 | 15.65M |
| 486 | ALLR | Allarity Therapeutics, Inc. | 21.01M | - | 89,102 | - |
| 487 | CASI | CASI Pharmaceuticals, Inc. | 20.96M | -1.92% | 38,069 | 26.85M |
| 488 | BCTX | BriaCell Therapeutics Corp. | 20.64M | -55.49% | 5,443,499 | - |
| 489 | KTTA | Pasithea Therapeutics Corp. | 20.32M | 0.51% | 249,334 | - |
| 490 | CLGN | CollPlant Biotechnologies Ltd. | 20.31M | -3.05% | 10,298 | 2.48M |
| 491 | LIMN | Liminatus Pharma, Inc. | 20.30M | -1.17% | 57,729 | - |
| 492 | BCAB | BioAtla, Inc. | 20.01M | 9.99% | 3,171,788 | 11.00M |
| 493 | CVKD | Cadrenal Therapeutics, Inc. | 19.64M | -3.11% | 46,424 | - |
| 494 | LEXX | Lexaria Bioscience Corp. | 19.46M | -3.34% | 223,555 | 522.00K |
| 495 | VYNE | VYNE Therapeutics Inc. | 18.86M | 0.21% | 231,793 | 524.00K |
| 496 | OSRH | OSR Holdings, Inc. | 18.85M | -1.05% | 2,247,973 | -90.52K |
| 497 | LSTA | Lisata Therapeutics, Inc. | 18.35M | -2.35% | 16,756 | 1.07M |
| 498 | CTXR | Citius Pharmaceuticals, Inc. | 17.91M | 0.65% | 181,570 | - |
| 499 | KAPA | Kairos Pharma, Ltd. | 17.91M | 4.87% | 118,593 | - |
| 500 | KALA | KALA BIO, Inc. | 17.87M | 3.87% | 1,448,714 | - |
| 501 | PMN | ProMIS Neurosciences, Inc. | 17.52M | -0.25% | 2,484 | - |
| 502 | ITRM | Iterum Therapeutics plc | 17.22M | -2.98% | 203,705 | 390.00K |
| 503 | HOTH | Hoth Therapeutics, Inc. | 16.21M | -0.48% | 109,915 | - |
| 504 | COCP | Cocrystal Pharma, Inc. | 15.99M | 6.42% | 303,977 | - |
| 505 | CLRB | Cellectar Biosciences, Inc. | 15.88M | -7.30% | 196,973 | - |
| 506 | APLT | Applied Therapeutics, Inc. | 15.23M | -0.79% | 4,862,508 | 1.00M |
| 507 | SNSE | Sensei Biotherapeutics, Inc. | 15.11M | 1.87% | 23,993 | - |
| 508 | BCDA | BioCardia, Inc. | 15.07M | 2.16% | 55,481 | 3.00K |
| 509 | TRAW | Traws Pharma, Inc. | 14.14M | 9.94% | 1,256,901 | 2.85M |
| 510 | SNGX | Soligenix, Inc. | 13.92M | 0.73% | 316,343 | 2.34K |
| 511 | NCNA | NuCana plc | 13.86M | -5.67% | 51,823 | - |
| 512 | SYBX | Synlogic, Inc. | 13.22M | 0.89% | 7,033 | 8.00K |
| 513 | AEON | AEON Biopharma, Inc. | 13.11M | 1.61% | 237,535 | - |
| 514 | GRDX | GridAI Technologies Corp. | 13.01M | -2.03% | 36,248 | - |
| 515 | MBRX | Moleculin Biotech, Inc. | 12.75M | -3.50% | 104,290 | - |
| 516 | TPST | Tempest Therapeutics, Inc. | 12.56M | -6.59% | 64,032 | - |
| 517 | BLRX | BioLineRx Ltd. | 12.41M | - | 27,864 | 12.74M |
| 518 | IMNN | Imunon, Inc. | 12.41M | -3.95% | 93,371 | - |
| 519 | BOLT | Bolt Biotherapeutics, Inc. | 12.38M | 7.68% | 71,066 | 5.20M |
| 520 | AKTX | Akari Therapeutics, Plc | 12.25M | -4.16% | 238,625 | - |
| 521 | EDSA | Edesa Biotech, Inc. | 12.17M | -1.35% | 23,186 | - |
| 522 | PHIO | Phio Pharmaceuticals Corp. | 12.06M | -5.08% | 239,588 | - |
| 523 | MTVA | MetaVia Inc. | 11.93M | -30.06% | 262,039 | - |
| 524 | LGVN | Longeveron Inc. | 11.90M | 1.71% | 107,933 | 1.44M |
| 525 | CRIS | Curis, Inc. | 11.69M | 0.90% | 663,827 | 11.65M |
| 526 | NCEL | NewcelX Ltd. | 11.21M | -0.40% | 114,204 | - |
| 527 | CMMB | Chemomab Therapeutics Ltd. | 10.89M | -1.12% | 43,325 | - |
| 528 | GDTC | CytoMed Therapeutics Limited | 10.79M | -23.35% | 147,018 | 573.19K |
| 529 | ABP | Abpro Holdings, Inc. | 10.58M | 0.13% | 2,080 | 183.00K |
| 530 | BRTX | BioRestorative Therapies, Inc. | 10.47M | - | 13,929 | 383.40K |
| 531 | INAB | IN8bio, Inc. | 10.24M | 1.84% | 70,936 | - |
| 532 | ICU | SeaStar Medical Holding Corporation | 10.06M | -2.79% | 220,231 | 881.00K |
| 533 | ERNA | Ernexa Therapeutics Inc. | 9.97M | 2.42% | 26,643 | 1,000.00 |
| 534 | EVGN | Evogene Ltd. | 9.46M | 1.94% | 42,121 | 8.02M |
| 535 | QNRX | Quoin Pharmaceuticals, Ltd. | 9.46M | 3.30% | 19,008 | - |
| 536 | PMCB | PharmaCyte Biotech, Inc. | 9.27M | 0.63% | 88,239 | - |
| 537 | BIVI | BioVie Inc. | 9.12M | -4.72% | 79,581 | - |
| 538 | APVO | Aptevo Therapeutics Inc. | 8.99M | 1.41% | 72,189 | - |
| 539 | IMRN | Immuron Limited | 8.71M | -14.17% | 121,858 | 4.78M |
| 540 | PULM | Pulmatrix, Inc. | 8.66M | 1.72% | 19,449 | 3.00K |
| 541 | APM | Aptorum Group Limited | 8.63M | -0.93% | 45,122 | - |
| 542 | ALZN | Alzamend Neuro, Inc. | 8.63M | -4.22% | 24,056 | - |
| 543 | RNAZ | TransCode Therapeutics, Inc. | 8.27M | 5.62% | 32,001 | - |
| 544 | CLDI | Calidi Biotherapeutics, Inc. | 8.20M | 1.82% | 16,451 | - |
| 545 | KPRX | Kiora Pharmaceuticals, Inc. | 8.14M | 1.37% | 32,651 | 20.00K |
| 546 | XTLB | XTL Biopharmaceuticals Ltd. | 8.10M | -12.15% | 1,725,088 | 968.00K |
| 547 | ADXN | Addex Therapeutics Ltd | 7.97M | -6.70% | 2,497 | 198.82K |
| 548 | MBIO | Mustang Bio, Inc. | 7.88M | -0.92% | 57,967 | - |
| 549 | PCSA | Processa Pharmaceuticals, Inc. | 7.84M | 7.45% | 161,617 | - |
| 550 | TOVX | Theriva Biologics, Inc. | 7.16M | -4.88% | 2,822,665 | - |
| 551 | PPBT | Purple Biotech Ltd | 7.09M | -1.14% | 84,288 | - |
| 552 | GTBP | GT Biopharma, Inc. | 7.02M | -3.71% | 678,968 | - |
| 553 | BGMS | Bio Green Med Solution, Inc. | 7.01M | 2.88% | 49,679 | 81.00K |
| 554 | GNPX | Genprex, Inc. | 6.66M | 19.58% | 2,680,689 | - |
| 555 | SLXN | Silexion Therapeutics Corp | 6.60M | - | 12,167 | - |
| 556 | CELZ | Creative Medical Technology Holdings, Inc. | 6.47M | 1.65% | 184,642 | 6.00K |
| 557 | ACXP | Acurx Pharmaceuticals, Inc. | 6.43M | 0.37% | 35,605 | - |
| 558 | ASBP | Aspire Biopharma Holdings, Inc. | 6.31M | -26.44% | 72,892,602 | 1.94K |
| 559 | APRE | Aprea Therapeutics, Inc. | 6.29M | -0.28% | 95,101 | 488.24K |
| 560 | ADIL | Adial Pharmaceuticals, Inc. | 6.20M | -1.15% | 397,933 | - |
| 561 | TCRT | Alaunos Therapeutics, Inc. | 6.12M | 4.58% | 14,345 | 6.00K |
| 562 | CYCN | Cyclerion Therapeutics, Inc. | 5.79M | -0.65% | 121,468 | 2.86M |
| 563 | PPCB | Propanc Biopharma, Inc. | 5.67M | -2.21% | 24,859 | - |
| 564 | CANF | Can-Fite BioPharma Ltd. | 5.61M | 3.62% | 52,160 | 560.00K |
| 565 | DCOY | Decoy Therapeutics Inc. | 5.55M | -30.40% | 4,072,939 | - |
| 566 | INDP | Indaptus Therapeutics, Inc. | 5.41M | 1.31% | 66,008 | - |
| 567 | REVB | Revelation Biosciences, Inc. | 5.33M | -0.57% | 109,278 | - |
| 568 | VIVS | VivoSim Labs, Inc. | 5.24M | - | 23,781 | 140.00K |
| 569 | SILO | Silo Pharma, Inc. | 5.22M | 1.75% | 46,866 | 72.10K |
| 570 | XBIO | Xenetic Biosciences, Inc. | 5.06M | - | 18,397 | 2.86M |
| 571 | GOVX | GeoVax Labs, Inc. | 4.91M | - | 298,810 | 3.35M |
| 572 | MTNB | Matinas BioPharma Holdings, Inc. | 4.55M | -4.57% | 10,006 | - |
| 573 | GLMD | Galmed Pharmaceuticals Ltd. | 4.51M | -0.83% | 73,279 | - |
| 574 | ENVB | Enveric Biosciences, Inc. | 4.25M | 10.37% | 100,175 | - |
| 575 | XRTX | XORTX Therapeutics Inc. | 4.16M | -0.84% | 8,950 | - |
| 576 | PHGE | BiomX Inc. | 4.03M | 16.30% | 82,826 | - |
| 577 | CNSP | CNS Pharmaceuticals, Inc. | 3.85M | 0.98% | 9,310 | - |
| 578 | OGEN | Oragenics, Inc. | 3.83M | 4.65% | 32,258 | - |
| 579 | CMND | Clearmind Medicine Inc. | 3.67M | 0.41% | 1,264,178 | - |
| 580 | SPRC | SciSparc Ltd. | 3.54M | -11.84% | 1,032,800 | 1.31M |
| 581 | JAGX | Jaguar Health, Inc. | 3.47M | 10.61% | 984,466 | 11.79M |
| 582 | ENSC | Ensysce Biosciences, Inc. | 3.38M | 0.50% | 59,347 | 4.49M |
| 583 | LYRA | Lyra Therapeutics, Inc. | 3.35M | -5.03% | 31,529 | 600.00K |
| 584 | SCNI | Scinai Immunotherapeutics Ltd. | 3.33M | 15.59% | 89,912 | 1.15M |
| 585 | CDIO | Cardio Diagnostics Holdings, Inc. | 3.32M | -0.55% | 177,085 | 15.78K |
| 586 | GRI | GRI Bio, Inc. | 3.32M | 10.55% | 1,881,466 | - |
| 587 | ARTL | Artelo Biosciences, Inc. | 3.25M | 6.62% | 205,547 | - |
| 588 | HCWB | HCW Biologics Inc. | 3.05M | -5.83% | 19,899 | 422.03K |
| 589 | AZTR | Azitra, Inc. | 2.96M | 0.04% | 2,565,929 | 7.50K |
| 590 | BBLG | Bone Biologics Corporation | 2.89M | -1.23% | 26,277 | - |
| 591 | DRMA | Dermata Therapeutics, Inc. | 2.59M | 3.77% | 156,463 | - |
| 592 | VRAX | Virax Biolabs Group Limited | 2.47M | 7.48% | 314,407 | 2.99K |
| 593 | ONCO | Onconetix, Inc. | 2.47M | 7.43% | 23,323 | 1.22M |
| 594 | CDT | CDT Equity Inc. | 2.43M | - | 28,296 | - |
| 595 | SXTP | 60 Degrees Pharmaceuticals, Inc. | 2.02M | -9.57% | 693,000 | 1.36M |
| 596 | BDRX | Biodexa Pharmaceuticals Plc | 1.75M | -8.73% | 125,771 | 104.90K |
| 597 | PBM | Psyence Biomedical Ltd. | 1.46M | -0.54% | 129,512 | - |
| 598 | ADTX | Aditxt, Inc. | 1.30M | -2.39% | 206,458 | 5.95K |
| 599 | MLEC | Moolec Science SA | 944.32K | -28.11% | 109,747 | 7.83M |
| 600 | ELAB | PMGC Holdings Inc. | 662.27K | -11.44% | 247,594 | 285.95K |